Preservation of cholinergic activity and prevention of neuron death by CEP-1347/KT-7515 following excitotoxic injury of the nucleus basalis magnocellularis

Neuroscience

Volumn 86, Issue 2, 1998, Pages 461-471

  Saporito, M S ^a   Brown, E R ^a   Carswell, S ^a   DiCamillo, A M ^a   Miller, M S ^a   Murakata, C ^b   Neff, N T ^a   Vaught, J L ^a   Haun, F A ^a  

^a CEPHALON INC   (United States)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Cholinergic; FluoroGold; K 252a; Nerve growth factor; Neuroprotection; Nucleus basalis magnocellularis

Indexed keywords

CARBAZOLE DERIVATIVE; CEP 1347; CHOLINE ACETYLTRANSFERASE; FLUOROGOLD; IBOTENIC ACID; K 252A; PROTEIN KINASE C; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CHOLINERGIC ACTIVITY; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOSE RESPONSE; ENZYME ACTIVITY; FOREBRAIN; MAGNOCELLULAR NUCLEUS; MALE; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032100520     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00059-1     Document Type: Article

References (59)

1. Arendt T., Bigl V., Arendt A., Tennstedt A. Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease. Acta neuropath. 61:1983;101-108.
2. Berg M. M., Sternber D. W., Parada L. F., Chao M. V. K-252a inhibits nerve growth factor-induced trk proto-oncogene tyrosine phosphorylation and kinase activity. J. biol. Chem. 267:1992;13-16.
3. Book A. A., Wiley R. G., Schweitzer J. B. 192 IgG-saporin: I. Specific lethality for cholinergic neurons in the basal forebrain of the rat. J. Neuropath. exp. Neurol. 53:1994;95-102.
4. Borasio G. D. Differential effects of the protein kinase inhibitor K-252a on the in vitro survival of chick embryonic neurons. Neurosci. Lett. 108:1990;207-212.
5. Carlsen J., Zaborszky L., Heimer L. Cholinergic projections from the basal forebrain to the basolateral amygdaloid complex: a combined retrograde fluorescent and immunohistochemical study. J. comp. Neurol. 234:1985;155-167.
6. Cavicchioli L., Flanigan T. P., Dickson J. G., Vantini G., Dal Tosos R., Fusco M., Walsh F. S., Leon A. Choline acetyltransferase messenger RNA expression in developing and adult rat brain: regulation by nerve growth factor. Molec. Brain Res. 9:1991;319-325.
7. Cheng B., Barger S. W., Mattson M. P. Staurosporine, K-252a and K-252b stabilize calcium homeostasis and promote survival of CNS neurons in the absence of glucose. J. Neurochem. 62:1994;1319-1329.
8. Clarke P. G. H. How inaccurate is the Abercrombie correction factor for cell counts? Trends Neurosci. 15:1992;211-212.
9. Cossette P., Umbriaco D., Zamar N., Hamel E., Descarries L. Recovery of choline acetyltransferase activity without sprouting of the residual acetylcholine innervation in adult rat cerebral cortex after lesion of the nucleus basalis. Brain Res. 630:1993;195-206.
10. Coyle J. T. AD: a disorder of cortical cholinergic innervation. Science. 219:1983;1184-1190.
11. Davis K. L., Thal L. J., Gamzu E. R., Davis C. S., Woolson R. F., Gracon S. I., Drachman D. A., Schneider L. S., Whitehouse P. J., Hoover T. M., Morris J. C., Kawas C. H., Knopman D. S., Earl N., Kuman V., Doody R. S., T C S Group A double-blind, placebo-controlled multicellular study of tacrine for Alzheimer's disease. New Eng. J. Med. 327:1992;1253-1259.
12. Dekker A. J., Fagan A. M., Gage F. H., Thal L. J. Effects of brain derived neurotrophic factor and nerve growth factor on remaining neurons in the lesioned nucleus basalis magnocellularis. Brain Res. 639:1994;149-155.
13. Dekker A. J., Gage F. H., Thal L. J. Delayed treatment with NGF improves acquisition of a spatial task in rats with lesions of the nucleus basalis magnocellularis: evaluation of the involvement of different neurotransmitter systems. Neuroscience. 48:1992;111-119.
14. Dekker A. J., Thal L. J. Effect of delayed treatment with nerve growth factor on choline acetyltransferase activity in the cortex of rats with lesions of the nucleus basalis magnocellularis: dose requirements. Brain Res. 584:1992;55-63.
15. Dekker A. J., Winkler J., Ray J., Thal L. J., Gage F. H. Grafting of nerve growth factor-producing fibroblasts reduces behavioral deficits in rats with lesions of the nucleus basalis magnocellularis. Neuroscience. 60:1994;299-309.
16. Dunnet S. B., Everitt B. J., Robbins T. W. The basal forebrain-cortical cholinergic system: interpreting the function consequences of excitotoxic lesions. Trends Neurosci. 14:1991;494-501.
17. Fibiger H. C. The organization and some projections of cholinergic neurons of the mammalian forebrain. Brain Res. Rev. 4:1982;327-388.
18. Fibiger H. C. Cholinergic mechanisms in learning memory and dementia: a review of recent evidence. Trends Neurosci. 14:1991;220-223.
19. Fonnum F. A rapid radiochemical method for the determination of choline acetyltransferase. J. Neurochem. 24:1975;407-409.
20. Fusco M., Oderfeld-Nowak B., Vantini G., Schiavo N., Gradkowska M., Zaremba M., Leon A. Nerve growth factor affects uninjured, adult rat septohippocampal cholinergic neurons. Neuroscience. 33:1989;47-52.
21. Ginsberg S. D., Portera-Cailliau C. and Martin L. J. (1997) Fimbria-fornix transection and excitotoxicity produce similar neurodegeneration in septum. Neuroscience (in press).
22. Glicksman M. A., Forbes M. E., Prantner J. E., Neff N. T. K-252a promotes survival and choline acetyltransferase activity in striatal and basal forebrain neuronal cultures. J. Neurochem. 64:1995;1502-1512.
23. Glicksman M. A., Prantner J. E., Meyer S. L., Forbes M. E., Dasgupta M., Lewis M. E., Neff N. T. K-252a and staurosporine promote choline acetyltransferase activity in spinal cord cultures. J. Neurochem. 61:1993;210-221.
24. Goodman Y., Mattson M. P. Staurosporine and K-252a compounds protect hippocampal neurons against amyloid β-peptide toxicity and oxidative injury. Brain Res. 650:1994;170-174.
25. Haroutunian V., Kanof P. D., Davis K. L. Attenuation of nucleus basalis of Meynert lesion-induced cholinergic deficits by nerve growth factor. Brain Res. 487:1989;200-203.
26. Hartikka J., Hefti F. Development of septal cholinergic neurons in culture:plating density and glial cells modulate effects of NGF on surviving fiber growth, and expression of transmitter-specific enzymes. J. Neurosci. 8:1988;2967-2985.
27. Hashimoto S. K-252a, a potent protein kinase inhibitor, blocks NGF-induced neurite outgrowth and changes in the phosphorylation of proteins in PC12h cells. J. Cell Biol. 107:1988;1531-1539.
28. Hu L., Cote S. L., Cuello C. Differential modulation of the cholinergic phenotype of the nucleus basalis magnocelluaris neurons by applying NGF at the cell body or cortical terminal fields. Expl Neurol. 143:1997;162-171.
29. Kaneko M., Saito Y., Saito H., Matsumoto T., Matsuda Y., Vaught J. L., dionne C. A., Angeles T. S., Glicksman M. A., Neff N. T., Rotella D. P., Kauer J. C., Mallamo J. P., Hudkins R. L. and Murakata C. (1997) Neurotrophic 3,9-alkylthiomethyl- and alkoxymethyl-K-252a derivatives. J. Med. Chem., Jan. 1997, (Submitted).
30. Kase H., Iwahashi K., Nakanishi S., Matsuda Y., Yamada K., Takahashi M., Murakata C., Sato A., Kaneko M. K-252a compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem. biophys. Res. Commun. 142:1987;436-440.
31. Knusel B., Hefti F. K-252 compounds; modulators of neurotrophin signal transduction. J. Neurochem. 59:1992;1987-1996.
32. Koizumi S., Contreras M. L., Matsuda Y., Hama T., Lazarovici P., Guroff G. K-252a: a specific inhibitor of of the action of nerve growth factor on PC12 cells. J. Neurosci. 8:1988;715-721.
33. Li Y., Holtzman D. M., Kromer L. F., Kaplan D. R., Chua-Couzens J., Clary D. O., Knusel B., Mobley W. C. Regulation of TrkA and ChAT expression in developing rat basal forebrain: evidence that both exogenous and endogenous NGF regulate differentiation of cholinergic neurons. J. Neurosci. 15:1995;2888-2905.
34. Lindefors N., Boatel M. L., Mahy N., Persson H. Widespread neuronal degeneration after ibotenic acid lesioning of cholinergic neurons in the nucleus basalis revealed by in situ hybridization. Neurosci. Lett. 135:1992;262-264.
35. Lorenzi M. V., Knusel B., Hefti F., Strauss W. L. Nerve growth factor regulation of choline acetyltransferase gene expression in rat embryo basal forebrain cultures. Neurosci. Lett. 140:1992;185-188.
36. Mandel R. J., Gage F. H., Thal L. J. Spatial learning in rats: correlation with cortical choline acetyltransferase and improvement with NGF following nbm damage. Expl Neurol. 104:1989;208-217.
37. Maroney A. C., Glicksman M. A., Basma A. N., Walton K. M., Knight E., Murphy C., Bartlett B. A., Finn J. P., Angeles T., Matsuda Y., Neff N. T. and Dionne C. A. (1997) Motoneuron apoptosis is blocked by CEP-1347/KT-7515, a novel inhibitor of the JNK signaling pathway. J. Neurosci. (in press).
38. Maroney A. C., Lipfert L., Forbes M. E., Glicksman M. A., Neff N. T., Siman R., Dionne C. A. K-252a induces tyrosine phosphorylation of the focal adhesion kinase and neurite outgrowth in human neuroblastoma SH-SY5Y cells. J. Neurochem. 64:1995;540-549.
39. Matsuda Y., Fukuda J. Inhibition by K-252a, a new inhibitor of protein kinase, of nerve growth factor-induced neurite outgrowth of chick embryo dorsal root ganglion cells. Neurosci. Lett. 87:1988;11-17.
40. McKinney M., Coyle J. T., Hedreen J. C. Topographic analysis of the innervation of the rat neocortex and hippocampus by the basal forebrain cholinergic system. J. comp. Neurol. 217:1983;103-121.
41. Murray C. L., Fibiger H. C. Pilocarpine and physostigmine attenuate spatial memory impairments produced by lesions of the nBM. Behav. Neurosci. 100:1986;23-32.
42. Nabeshima T., Ogawa S., Nishimura H., Fuji K., Kameyama T., Sasaki Y. Staurosporine, a PKC inhibitor, attenuates basal forebrain lesion induced amnesia and cholinergic neuronal deficit. Neurosci. Lett. 122:1990;13-16.
43. Nye S. H., Squinto S. P., Glass D. J., Stitt T. N., Hantzopoulus P., Machi M. J., Lindsay N. S., Ip N. Y., Yancoupoulus G. D. K-252a and staurosporine selectively block autophosphorylation of neurotrophin receptors and neurotrophin-mediated responses. Molec. Biol. Cell. 3:1992;677-683.
44. Ohmichi M., Decker S. J., Pang L., Saltiel A. R. Inhibition of the cellular actions of nerve growth factor by staurosporine and K-252a result from the attenuation of the activity of the trk tyrosine kinase. Biochemistry. 31:1992;4034-4039.
45. Olton D. S. and Wenk G. L. (1987) Dementia: animal models of the cognitive impairments produced by degeneration of the basal forebrain cholinergic system. In Psychopharmacology: The Third Generation of Progress (ed. Meltzer H. Y.), pp. 941-953. Raven, New York.
46. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic, San Diego, CA.
47. Portera-Cailliau C., Hedreen J. C., Price D. L., Koliatsos V. E. Evidence for apoptotic cell death in Huntingdon disease and excitotoxic animal models. J. Neurosci. 15:1995;3775-3787.
48. Rasouly D., Rahamim E., Ringel I., Ginzburg I., Murakata C., Matsuda Y., Lazarovici P. Neurites induced by staurosporine in PC12 cells are resistant to colchicine and express high levels of Tau proteins. Molec. Pharmac. 45:1994;29-35.
49. Rye D. B., Wainer B. H., Mesulam M.-M., Mufson E. J., Sapers C. B. Cortical projections arising from the basal forebrain: a study of cholinergic and noncholinergic components employing combined retrograde tracing and immunohistochemical localization of choline acetyltransferase. Neuroscience. 13:1984;627-643.
50. Smith G. Animal models of Alzheimer's disease: experimental cholinergic denervation. Brain Res. Rev. 13:1988;103-118.
51. Smolen A. J., Wright L. L., Cunningham T. J. Neuron numbers in the superior cervical ganglion of the rat: a critical method of cell counting. J. Neurocytol. 12:1983;739-750.
52. Stephens P. H., Cuello C., Sofroniew V., Pearson C. A., Tagari P. Effect of unilateral decortication on choline acetyltransferase activity in the nucleus basalis and other areas of the rat brain. J. Neurochem. 45:1985;1021-1026.
53. Tarpley P., Lamballe F., Barbacid M. K-252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors. Oncogene. 7:1992;371-381.
54. Wenk G. L. Neuroprotection and selective vulnerability of neurons within the nucleus basalis magnocellularis. Behav. Brain Res. 72:1996;17-24.
55. Wenk G., Cribbs B., McCrall L. Nucleus basalis magnocellularis: optimal coordinates for selective reduction of choline acetyltransferase in frontal neocortex by ibotenic acid injection. Expl Brain Res. 56:1984;335-340.
56. Wenk G. L., Harrington C. A., Tucker D. A., Rance N. E., Walker L. C. Basal forebrain neurons and memory: a biochemical, histological, and behavioral study of differential vulnerability to ibotenate and quisqualate. Behav. Neurosci. 106:1992;909-923.
57. Whitehouse P. J., Price D. L., Struble R. G., Clark A. W., Delong M. R. Alzheimers disease and senile dementia: loss of neurons in the basal forebrain. Science. 215:1982;237-1239.
58. Winkler J., Thal L. J. Effects of nerve growth factor treatment on rats with lesions of the nucleus basalis magnocellularis produced by ibotenic acid, quisqualic acid, and AMPA. Expl Neurol. 136:1995;234-250.
59. Xia Z., Dickens M., Raingeaud J., Davis R. J., Greenberg M. E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.